Former FDA commissioner Scott Gottlieb has stoked controversy after being appointed to Pfizer’s board of directors, just a few weeks after leaving his government post.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
